<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04095013</url>
  </required_header>
  <id_info>
    <org_study_id>dr.sanaurooj@yahoo.com</org_study_id>
    <nct_id>NCT04095013</nct_id>
  </id_info>
  <brief_title>Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section</brief_title>
  <official_title>Comparative Evaluation of Intrathecal Bupivacaine-fentanyl and Bupivacaine-dexmedetomidine for Elective Low Segment Caesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dow University of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dow University of Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the primary objective of the study is to compare the onset and recovery times of sensory and
      motor blockade of the two study drugs intrathecally with low dose bupivacaine The secondary
      objectives of the study are to observe hemodynamics, side effects profile, and duration of
      postoperative analgesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study is undertaken to compare the effect of two drugs
      intrathecally.edexmedetomidine and fentanyl with a low dose of bupivacaine and assess the
      adequacy of the block, side effect profile and postoperative analgesia. The two drugs have
      been studied separately but the comparative data is scarcely available both at national and
      international level. A particular agent is a dexmedetomidine that has been introduced in the
      investiagator's setup for the first time so this research will be of great importance in
      adding its multiple uses other than being used as ICU and procedural sedation agent.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2019</start_date>
  <completion_date type="Actual">July 15, 2019</completion_date>
  <primary_completion_date type="Actual">June 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomize controlled trial (RCT)</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Patients were randomly allocated into two groups and will be blinded to the study drugs. The drugs will be chosen by seal envelope method by principal investigator and co-investigator. The drugs will be filled in the syringes and the syringes handed over to on floor consultant anesthetist who are blinded to the study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Time till T10 dermatome achieved (Sec)</measure>
    <time_frame>Post operative initial hour</time_frame>
    <description>Spinal block characteristics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of maximum bromage achieved (Sec)</measure>
    <time_frame>Post operative initial hour</time_frame>
    <description>Spinal block characteristics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Regression time to T10 dermatome (Min)</measure>
    <time_frame>Post operative initial hour</time_frame>
    <description>Spinal block characteristics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of complete motor recovery (Min)</measure>
    <time_frame>Post operative initial hour</time_frame>
    <description>Spinal block characteristics</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative pain score</measure>
    <time_frame>1 hour</time_frame>
    <description>VAS score indicate 0 no pain 10 severe pain. Pain score was noted down</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative pain score</measure>
    <time_frame>2 hour</time_frame>
    <description>VAS score indicate 0 no pain 10 severe pain. Pain score was noted down</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative pain score</measure>
    <time_frame>3 hour</time_frame>
    <description>VAS score indicate 0 no pain 10 severe pain. Pain score was noted down</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Post-operative pain score</measure>
    <time_frame>4 hour</time_frame>
    <description>VAS score indicate 0 no pain 10 severe pain. Pain score was noted down</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nausea</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Sensation to throw out stomach contents</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vomiting</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Act of throwing out stomach contents through mouth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pruritus</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Unpleasing sensation on the skin that provokes to scratch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory distress</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Difficulty in breathing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shivering</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>The act of shaking slightly and uncomfortably due to felling of cold temperature</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bradycardia</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Heat rate less than &lt;60 bpm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hypotension</measure>
    <time_frame>24 hours Post operative</time_frame>
    <description>Decrease in BP greater than 20% of baseline</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>Immediate after giving intrathecal injection and positoning</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>at 5 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>SBP</measure>
    <time_frame>at 10 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>at 15 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>at 20 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>Immediate after giving intrathecal injection and positoning</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>at 5 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>at 10 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>at 15 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>at 20 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>Immediate after giving intrathecal injection and positoning</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>at 5 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>at 10 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>at 15 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart Rate</measure>
    <time_frame>at 20 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>Immediate after giving intrathecal injection and positoning</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>at 5 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>at 10 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>at 15 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>oxygen saturation</measure>
    <time_frame>at 20 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>Baseline</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>Immediate after giving intrathecal injection and positoning</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>at 5 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>at 10 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>at 15 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <other_outcome>
    <measure>respiratory rate</measure>
    <time_frame>at 20 minute</time_frame>
    <description>Hemodynamics</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Cesarean Section Complications</condition>
  <arm_group>
    <arm_group_label>Group BF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hyperbaric Bupivacaine 10mg with fentanyl 10micrograms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group BD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine, fentanyl</intervention_name>
    <description>Group A: hyperbaric Bupivacaine 10mg with fentanyl 10micrograms,</description>
    <arm_group_label>Group BF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine, dexmedetomidine</intervention_name>
    <description>Group B: hyperbaric Bupivacaine 10 mg with dexmedetomidine5 micrograms</description>
    <arm_group_label>Group BD</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Term pregnancy Singleton ASA I and II, BMI &lt;35, elective C/section

        Exclusion Criteria:

        patient refusal, contraindications to spinal anaesthesia. ASA III and IV, PIH Pre
        Eclampsia, allergic to Local Anesthetic, fetal anomalies.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant women</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Civil Hospital Karachi</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>75520</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DUHS, Civil hospital Karachi (CHK)</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>75520</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 14, 2019</study_first_submitted>
  <study_first_submitted_qc>September 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 19, 2019</study_first_posted>
  <last_update_submitted>September 17, 2019</last_update_submitted>
  <last_update_submitted_qc>September 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dow University of Health Sciences</investigator_affiliation>
    <investigator_full_name>Sana Urooj</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Elective low segment caesarean section</keyword>
  <keyword>Intrathecal</keyword>
  <keyword>bupivacaine-fentanyl</keyword>
  <keyword>bupivacaine-dexmedetomidine</keyword>
  <keyword>sensory block</keyword>
  <keyword>complications</keyword>
  <keyword>hemodynamics</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

